Click here to download Final Program as a pdf.
| Saturday, July 26, 2014 |
Sunday, July 27, 2014 |
Monday, July 28, 2014 |
| Oral Presentations | Oral Presentations | Oral Presentations |
| Poster Sessions | Poster Sessions | Poster Sessions |
Monday, July 28, 2014
| 08:30-11:00 | Grand Ballroom | |
PL17 Plenary
Session: Chairs: |
||
| 08:30 | IS THE DASH DIET THE OPTIMAL DIET FOR HEART FAILURE PATIENTS? (Invited Lecture) M.A. Silver Advocate Christ Medical Center, University of Illinois. IL, USA |
404 |
| 08:45 | MEDITERRANEAN DIET AND SECONDARY PREVENTION OF CVD (Invited Lecture) D.B. Panagiotakos Harokopio University, Athens, Greece |
405 |
| 09:00 | LOOKING BACK ON THE LOOK AHEAD TRIAL (Invited Lecture) E. Barrett-Connor University of California San Diego, La Jolla, CA, USA |
406 |
| 09:15 | SATURATED FAT INTAKE AND THE GENESIS OF CORONARY ARTERY DISEASE – WHERE’S THE EVIDENCE? (Invited Lecture) S. Vallurupalli, J.L. Mehta University of Arkansas for Medical Sciences, Little Rock, AR, USA |
407 |
| 09:30 | INTEGRATING NUTRITION EDUCATION INTO THE CARDIOVASCULAR CURRICULUM CHANGES MEDICAL STUDENT EATING HABITS (Invited Lecture) R. Zelis, E. Vargas Pennsylvania State University, Hershey Medical Center, Hershey, PA, USA |
408 |
| 09:45 | DO VITAMIN AND MINERAL SUPPLEMENTS HAVE A ROLE IN CARDIOVASCULAR DISEASE PREVENTION? (Invited Lecture) H.D. Sesso, Brigham and Women's Hospital, Boston, MA, USA |
409 |
| 10:00 | ALTERNATE HEALTHY EATING INDEX, MEDITERRANEAN AND DASH DIETARY PATTERNS AND RISK OF DEATH IN THE PHYSICIAN'S HEALTH STUDY (Invited Lecture) L. Djousse, A. Petrone, J.M. Gaziano Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA |
410 |
| 10:15 | RACIAL DIFFERENCES IN VITAMIN D/PARATHYROID HORMONE ENDOCRINE SYSTEM AND CARDIOVASCULAR DISEASE (Invited Lecture) Y. Song, Indiana University, Indianapolis, IN, USA |
411 |
| 10:30 | DIETARY FATTY ACID COMPOSITION AS A RISK FACTOR FOR CARDIOMETABOLIC DISORDERS: BEYOND THE CALORIES (Invited Lecture) L. Wang, Brigham and Women's Hospital, Boston, MA, USA |
412 |
| 10:45 | THE ROLE OF EXERCISE AND REHABILITATION FOR HEART FAILURE PATIENTS (Invited Lecture) C. Chrysohoou, Hippokration Hospital,University of Athens, Greece |
413 |
| 11:00 | COFFEE BREAK, VISIT POSTERS AND EXHIBITION | |
| MONDAY, July 28, 2014 | ||
| 08:30-10:45 | Martha’s Vineyard | |
|
PL18 Plenary Session: ADVANCES IN THE TREATMENT AND MANAGEMENT OF HEART FAILURE Chairs: P.A. Heidenreich, Palo Alto, CA, USA |
|
| 08:30 | THE MANAGEMENT OF PATIENTS WITH ADVANCED HEART FAILURE (Invited Lecture) V.H. Pitzalis East Carolina University, The Brody School of Medicine, Greenville, NC, USA |
414 |
| 08:45 | CAN WE PREVENT HEART FAILURE READMISSIONS? (Invited Lecture) P.A. Heidenreich Stanford University, Palo Alto, CA, USA |
415 |
| 09:00 | ROLE OF THE "PERIPHERY" IN HEART FAILURE AND PRESERVED EJECTION FRACTION (Invited Lecture) J.A. Chirinos University of Pennsylvania School of Medicine, Philadelphia, PA, USA |
416 |
| 09:15 | CARDIORENAL SYNDROME: NOT AS STRAIGHT FORWARD AS WE USED TO THINK (Invited Lecture) A. Kazory University of Florida, Gainesville, FL, USA |
417 |
| 09:30 | NEW TECHNOLOGIES TO IMPROVE CRT OUTCOME (Invited Lecture) K. Seidl Klinikum Ingolstadt, Germany |
418 |
| 09:45 | COLCHICINE AND NEW MANAGEMENT STRATEGIES FOR ACUTE AND RECURRENT PERICARDITIS (Invited Lecture) M. Imazio Maria Vittoria Hospital, Torino, Italy |
419 |
| 10:00 | SKELETAL MUSCLE HYPERTROPHY INDUCED BY NOVEL KAATSU REHABILITATION AND PREVENTION OF SARCOPENIA (Invited Lecture) |
420 |
| 10:15 | PERICARDIAL INVOLVEMENT FREQUENTLY COMPLICATING PULMONARY AND/OR SYSTEMIC SARCOID GRANULOMATOSIS. A LIFE-LONG, MULTI STAGE DISEASE, PERIODICAL STUDY IN 278 BIOPSY –PROVEN SARCOIDOSIS PATIENTS (Invited Lecture) I. Angomachalelis, K. George, N. Angomachalelis G. Papanikolaou General Hospital, Thessaloniki, Greece |
421 |
| 10:30 | IMATINIB: A NOVEL CANDIDATE FOR TREATMENT OF PERMEABILITY EDEMA (Invited Lecture) G.P. van Nieuw Amerongen VU University Medical Center, Amsterdam, The Netherlands |
422 |
| 10:45 | COFFEE BREAK, VISIT POSTERS AND EXHIBITION | |
| MONDAY, July 28, 2014 | ||
| 08:30 - 10:45 | Nantucket | |
| S33 Session: THE RELEVANCE OF GENETICS IN PROVIDING UNDERSTANDING AND TREATMENT FOR CARDIOVASCULAR DISEASE Chairs: M.J. Sanz, Valencia, Spain M. Zahid, Pittsburgh, PA, USA |
||
| 08:30 | PHARMACOGENETICS-GUIDED INDIVIDUAL WARFARIN DOSING IN A CARDIOLOGY CLINIC – A PERSPECTIVE OBSERVATORY STUDY W.Q. Fan, Y. Wu, B. Khalighi, A. Mirabbasi, R. Thachil, E.J. Mascarenhas, K. Khalighi Easton Hospital, Drexel University, Easton, PA, USA |
423 |
| 08:45 | A MICRO-RNA-410 REGULATED LIPOPROTEIN LIPASE POLYMORPHISM IS ASSOCIATED WITH TRIGLYCERIDES AND STROKE INCIDENCE D. Corella, O. Coltell, J.V. Sorli, R. Estruch, M. Fito, F. Aros, E. Ros, J. Lapetra, G.T. Saez, J.M. Ordovas Instituto de Salud Carlos III, Madrid, Spain |
424 |
| 09:00 | ATF3 PROTECT AGAINST PRESSURE OVERLOAD HEART FAILURE VIA BECLIN-1 PATHWAY C.F. Cheng, S.F. Li, H. Lin Tzu Chi General Hospital, Hualien, Taiwan |
425 |
| 09:15 | RAPID UP-REGULATION AND CLEARANCE OF DISTINCT CIRCULATING MICRORNAS AFTER PROLONGED AEROBIC EXERCISE A.L. Baggish, J. Park, P-K.Min, S. Isaacs, B.A. Parker, P.D. Thompson, C. Troyanos, P. D’Hemecourt, S. Dyer, M. Thiel, A. Hale, S.Y. Chan Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA |
426 |
| 09:30 | RANOLAZINE PREVENTS TRASTUZUMAB-CARDIOTOXICITY IN EXPERIMENTAL MODELS N. Maurea, C. Coppola, G. Piscopo, D. Rea, C. Maurea, F. Galletta, E. Esposito, I. Capasso, P. Maiolino, C. Arra National Cancer Institute Pascale Foundation IRCCS, Naples, Italy |
427 |
| 09:45 | VARIATION IN THE MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6 GENE, DAIRY INTAKE AND CARDIOVASCULAR RISK O. Coltell, C. Ortega-Azorin, M.A. Martinez-Gonzalez, J. Salas-Salvado, L. Serra-Majem, E. Gomez-Gracia, V. Ruiz-Gutierrez, M. Fiol, X. Pinto, D. Corella Instituto de Salud Carlos III, Madrid, Spain |
428 |
| 10:00 | GENE ELECTRO TRANSFER OF PVEGF INDUCES ANGIOGENESIS AND IMPROVES CARDIAC FUNCTION IN A PORCINE ISCHEMIA MODEL B. Hargrave, R. Strange, Jr., C. Lundberg, N. Burcus, A. Bulysheva, R. Heller Old Dominion University, Norfolk, VA, USA |
429 |
| 10:15 | THE FAMILY HISTORY AND GENETIC RISK DISCONNECT IN WOMEN B.T. Costello, R. Doukky, G.P. Lundberg, L.T. Braun, A.S. Volgman Rush University Medical Center, Chicago, Illinois, USA |
430 |
| 10:30 | REPETITIVE APPLICATION OF RESTRICTION OF MUSCLE BLOOD FLOW ENHANCES MTOR SIGNALING PATHWAYS IN A RAT MODEL T. Nakajima, T. Yasuda, S. Koide, Y. Sato, T. Tomaru, Y. Kano University of Electro-Communications, Tokyo, Japan |
431 |
| 10:45 | COFFEE BREAK, VISIT POSTERS AND EXHIBITION | |
| MONDAY, July 28, 2014 | ||
| 11:15 - 14:00 | Grand Ballroom | |
| PL19
Plenary Session: CURRENT CONCEPTS AND FUTURE DIRECTIONS IN ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROME Chairs: J.M. Gardin, Hackensack, NJ, USA |
||
| 11:15 | OLD AND EMERGING OPTIONS FOR TREATMENT OF REFRACTORY ANGINA: A CRITICAL APPRAISAL (Invited Lecture) U. Thadani University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA |
432 |
| 11:30 | MANAGEMENT OF STABLE ISCHEMIC HEART DISEASE: OVERVIEW OF RECENT GUIDELINES (Invited Lecture) J.M. Gardin Hackensack University Medical Center, NJ, USA |
433 |
| 11:45 | IN-VIVO RISK STRATIFICATION OF INDIVIDUAL CORONARY ARTERY PLAQUES:
EVOLVING PARADIGM FOR PREEMPTIVE MANAGEMENT OF PATIENTS WITH CAD (Invited Lecture) P.H. Stone Brigham & Women's Hospital, Boston, MA, USA |
434 |
| 12:00 | FRACTIONAL FLOW RESERVE (FFR) AT 2014- WHERE ARE WE AND WHERE IS IT GOING (Invited Lecture) E. Kaluski University Hospital, Newark, NJ, USA |
435 |
| 12:15 | IS ISCHEMIA UNIVERSAL IN A CHRONIC TOTAL OCCLUSION? (Invited Lecture) R. Sachdeva North Fulton Hospital, Roswell, GA, USA |
436 |
| 12:30 | OPTIMAL DURATION OF DUAL ANTIPLATELET THERAPY AFTER DES IMPLANTATION: EXCELLENT TRIAL AND FUTURE PERSPECTIVES (Invited Lecture) H-C. Gwon Sungkyunkwan University School of Medicine, Seoul, Republic of Korea |
437 |
| 12:45 | DUAL UTILIZATION OF EXERCISE ECHOCARDIOGRAMS AND MYOCARDIAL PERFUSION IN ASSESSING ISCHEMIA IN A CARDIOLOGY PRACTICE (Invited Lecture) Y. Charuzi, R.W. Gao, J. Mirocha Cedars Sinai Heart Institute, Los Angeles, CA, USA |
438 |
| 13:00 | ATYPICAL AND UNUSUAL CLINICAL PRESENTATIONS OF PATIENTS WITH ISCHEMIC HEART DISEASE (Invited Lecture) H.K. Reddy, R. Komatireddy, R.K. Sharma St. Louis University Medical School, St. Louis, Missouri, USA |
439 |
| 13:15 | STABLE ISCHEMIC HEART DISEASE: EVOLVING CONCEPTS AND THE ROLE OF ISCHEMIA (Invited Lecture) M.S. Sidhu Albany Medical College, Albany, NY, USA |
440 |
| 13:30 | CT FLOW METRICS BASED ON CONTRAST OPACIFICATION F.J. Rybicki, D.M. Mitsouras Applied Imaging Science Lab, Brigham and Women's Hospital, Boston, MA, USA |
442 |
| 13:45 | SHOULD DUAL ANTI-PLATELET THERAPY FOR CORONARY ARTERY DISEASE BE MORE OR LESS THAN 12 MONTHS? : A META-ANALYSIS D. Garcia, M. Ansari, C. Martinez, C. Alfonso, A. Benjo, M. Cohen, E. De Marchena University of Miami/Jackson Memorial Hospital, Miami, FL, USA |
441 |
| MONDAY, July 28, 2014 | ||
| 11:15-13:00 | Martha’s Vineyard | |
PL20
Plenary Session: Chairs: |
||
| 11:15 | THE MACROPHAGE A2B ADENOSINE RECEPTOR REGULATES OBESITY-INDUCED TISSUE INSULIN SENSITIVITY (Invited Lecture) K. Ravid, H. Johnston-Cox, A. Eisenstein, M. Koupenova-Zamor Boston University School of Medicine, Boston, MA, USA |
443 |
| 11:30 | METABOLIC SYNDROME CRITERIA: CAUSE VERSUS EFFECT OF CARDIOMETABOLIC DISEASE (Invited Lecture) T.B. Levine Drexel University College of Medicine, Philadelphia, PA, USA |
444 |
| 11:45 | MITOCHONDRIAL DYSFUNCTION AND DIABETIC HEART DISEASE (Invited Lecture) S. Kobayashi, Y. Huang, Q. Liang New York Institute of Technology, Old Westbury, NY, USA |
445 |
| 12:00 | BENEFIT AND RISKS OF ANTIDIABETIC TREATMENT IN PATIENTS WITH CORONARY ARTERY DISEASE AND HEART FAILURE (Invited Lecture) C.H. Saely VIVIT Institute, Academic Teaching Hospital, Feldkirch, Austria |
446 |
| 12:15 | SERENDIPITY IN MEDICINE; DOES CHANCE TRULY FAVOR THE PREPARED MIND? (Invited Lecture) R.W.W. Biederman Carnegie Mellon University, Allegheny General Hospital, Pittsburgh, PA, USA |
447 |
| 12:30 | HIGH CARDIOVASCULAR RISK IN NON-ALCOHOLIC FATTY LIVER DISEASE: A POSSIBLE ROLE FOR INCREASED OXIDATIVE STRESS? F. Angelico, M. Del Ben, L. Polimeni, F. Baratta, D. Pastori, R. Carnevali, S. Bartimoccia, F. Violi Sapienza University, Rome, Italy |
448 |
| 12:45 | IMPACT OF METABOLIC SYNDROME ON SUBCLINICAL ATHEROSCLEROSIS IN ASYMPTOMATIC INDIVIDUALS S.M. Jung, G.M. Park, C.J. Kim, J.S. Cho, M.W. Park, S.H. Her, S.W. Lee Daejeon St. Mary's Hospital, the Catholic University of Korea, Daejeon, Korea |
449 |
| MONDAY, July 28, 2014 | ||
| 11:15-14:00 | Adrienne Salon | |
|
S34 Session: DISEASE PATHWAYS AND NEW TREATMENT STRATEGIES IN HEART FAILURE AND CARDIOMYOPATHIES Chairs: J.A. Chirinos, Philadelphia, PA, USA |
|
| 11:15 | TREATING RAPID ATRIAL FIBRILLATION IN DECOMPENSATED HEART FAILURE: METOPROLOL IS SUPERIOR TO DILTIAZEM F. Katchi, S. Nagabandi, J. Shuster, E. Novak, S. Joseph Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA |
450 |
| 11:30 | PREDICTORS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) A. Kumar, A.K. Saluja, A. Khan, D. Gandhi, M.A. Morsy, W.I. Khalife University of Texas Medical Branch, Galveston, TX, USA |
451 |
| 11:45 | OPTIMIZING HEART FAILURE OUTCOMES: WHICH HOSPITAL CARE MODEL CAN WE LEARN FROM? P.M. Ndunda, M. Farhoud, H. Farhoud, K.J. Kallail Kansas University School of Medicine-Wichita, Wichita, KS, USA |
452 |
| 12:00 | COMPARATIVE EFFECTIVENESS OF TRANSITIONAL CARE SERVICES IN PATIENTS DISCHARGED FROM THE HOSPITAL WITH HEART FAILURE (HF): A META-ANALYSIS H.G.C. Van Spall, O. Mytton, M. Coppiens, T. Shiga, B. Haynes, S. Connolly Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada |
453 |
| 12:15 | INFLUENCE OF PREHYPERTENSION AND STAGE-1 HYPERTENSION ON THE OUTCOME OF ADULTS WITH HYPERTROPHIC CARDIOMYOPATHY Y.R. Manda, L.B. Chebrolu, J. Shirani St Luke's University Health Network, Bethlehem, PA, USA |
454 |
| 12:30 | ASSOCIATION OF HUMANIN A NOVEL MITOCHONDRIAL DERIVED PROTEIN AND HUMAN HEART FAILURE: RESULTS OF A PILOT INVESTIGATION H. Narayanasamy, N. Bardia, J. Wan, D. Lee, P. Cohen, L. Grazette Keck Medical School of USC, LA, CA, USA |
455 |
| 12:45 | DECREASED RENAL FUNCTION IS ASSOCIATED WITH HEART FAILURE READMISSION M.R. Vindhyal, B. Duran, H. Farhoud, K.J. Kallail KU School of Medicine, Wichita, Kansas, USA |
456 |
| 13:00 | EDHFIC: INITIAL EXPERIENCE WITH A NOVEL MULTIDISCIPLINARY COLLABORATION TO DECREASE HEART FAILURE ADMISSIONS A.S. Bhatt, C. Cosgrove, M. Moorer, A.J. Smally, J. Radojevic, D. Wencker, J.A. Gluck University of Connecticut School of Medicine, Farmington, CT, USA |
457 |
| 13:15 | COLCHICINE USE FOR THE PRIMARY PREVENTION OF POSTPERICARDIOTOMY SYNDROME (CUPP): A META-ANALYSIS C.K. Fomaneg, P.E.E Samonte, M.M. Sasondoncillo-Nadal, C.L.L Sim-Apura, L.P. Padua Philippine Heart Center, Quezon City, Philippines |
458 |
| 13:30 | TRASTUZMAB CARDIOTOXICITY DOCUMENTED BY SERIAL ASSESSMENT OF LEFT VENTRICULAR SYSTOLIC FUNCTION AND GLOBAL LONGITUDIANL PEAK STRAIN A.M. Cook, R.C. Phillion, K.J. Babbitt, L.L. Eberhart, D.E. Langholz, H.L. Sherman Spectrum Health Frederik Meijer Heart & Vascular Institute, Grand Rapids, MI, USA |
459 |
| 13:45 | PREDICTORS OF LEFT VENTRICULAR DYSFUNCTION AFTER ARTERIAL-VENOUS FISTULA PLACEMENT R. Dhingra, S. Tariq, J. Anderson, M. Gallichio, M. Torosoff Albany Medical College, Albany, NY, USA |
460 |
| Saturday, July 26, 2014 |
Sunday, July 27, 2014 |
Monday, July 28, 2014 |
| Oral Presentations | Oral Presentations | Oral Presentations |
| Poster Sessions | Poster Sessions | Poster Sessions |
Participant Information
News
Abstract Deadline extended to:
April 15, 2014
Final Program is now online.
. 
